The Effect of Antihistaminics on Mice Hypersensitive to H. Pertussis Vaccine * by Parfentjev, I. A.
THE EFFECT OF ANTIHISTAMINICS ON MICE
HYPERSENSITIVE TO H. PERTUSSIS VACCINE*
I. A. PARFENTJEV
In connection with several recent publications"' on reaction in children
after injection of H. pertussis vaccine, it might be of interest to report our
own observations on the action of antihistaminic drugs on mice sensitized
by this vaccine.
In a previous publication8 it was reported that treatment of mice with
H. pertussis vaccine renders these animals highly sensitive to histamine.
These findings were extended in a recent paper by Parfentjev and Sch-
leyer.10 Dependent on the vaccine dose and the mice selected for this type of
experiment, the LD50 of histamine in sensitized mice was found to be 1/306
to 1/120'° that of non-sensitized animals. It has also been shown8 that anti-
histaminic drugs, e.g. Bromothen [N,N-dimethyl-N'(2-pyridyl)-N'(5-
bromo-2-thenyl)-ethylene-diamine hydrochloride],' counteracted the hista-
mine effect in sensitized mice, thus indicating that this technique might be
used for the evaluation of anti-histaminic agents. A further advantage of
using experimentally sensitized mice might be seen in the fact that the im-
miunizing effect of H. pertussis vaccine also produced a hypersensitiveness
of the animals to H. pertussis protein-antigen.' This offered the possibility
of measuring the effect of antihistaminic drugs in mice against both his-
tamine shock and anaphylaxis using the same sensitization in both instances.
In order to determine the usefulness of the mouse assay in the evaluation
of antihistaminics, a number of experiments were carried out with the anti-
histaminic drug Thephorin, described by Lehmann' and Lehmann, Randall,
and Hagan;' this substance, the tartrate of 2-methyl-9-phenyl-2,3,4,9-
tetraphydro-1-pyridindene, appeared interesting because it bears no chemi-
cal relationship to any existing histamine antagonist.
The results of our experiments are presented in this paper.
Materials and methods
All experiments were carried out in white mice of 22-26 gm. originating from one
mouse colony.
Sensitization. The same H. pertussis vaccine and the same dosage were used as
described before.10 The sensitizing dose was given intra-abdominally.
Challenging injections. In the tests mice were used at the peak of sensitivity. It was
known from our preliminary experiments that the highest sensitivity toward histamine
was obtained 4-5 days after the administration of vaccine, while the optimal anaphyl-
active hypersensitiveness to H. pertussis protein was observed after 11-12 days.
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Histamine was given intra-abdominally as a solution of the diphosphate. For the
challenging injection of the antigen we applied a sterile detoxified formalin filtrate of
a culture of H. pertussis (detoxified H. pertussis antigen). This antigen, which con-
tains the proteins and other constituents of the organisms, was not toxic for normal
mice but produced anaphylaxis and killed sensitized animals with the symptoms
of acute shock. One-half ml. of this antigen was injected intravenously into the
sensitized mice.
Protection by Thephorin. Thephorin was injected intra-abdominally 15 minutes
before the challenge with histamine. If Thephorin was given per os, two treatments
of the drug were administered by stomach tube with a one-hour interval between them.
Four and a half hours after the second medication the challenging dose of histamine
or antigen was injected.
Each test was performed on 2-4 mice simultaneously and was repeated on animals
from several experimental lots of sensitized mice. Altogether 200 mice were used in
this study.
Experimental
The results of the experiments are given in Tables 1 and 2.
Table 1 shows that the standard dose of 25 mg. Thephorin/kg. protected
the majority of sensitized mice against 12 lethal doses of histamine, given
TABLE 1
PROTECTIVE EFFECT OF THEPHORIN TO.WARDs HISTAMINE SHOCK
IN MICE SENSITIZED BY H. PERTUSSIS VACCINE
Thephorin dose: 25 mg./kg. intra-abdominally.
Interval between Thephorin dose and histamine injection: 15 minutes.
No. surviving mice




* Based on 25 mg. histamine diphosphate/kg. as one lethal dose.
15 minutes later. There was no protection aganist 20 lethal doses. Oral
administration of Thephorin (Table 2) also exerted a striking effect on the
histamine shock as well as on the anaphylactic response to the specific
H. pertussis antigen, if higher doses (50-100 mg./kg.) of this antihistaminic
were given. Higher doses were necessary because of the long interval of
4Y2 hours between the administration of Thephorin and the injection of the
challenging dose of histamine used in mice as compared to guinea pigs.
The protective effect of oral Thephorin toward histamine was best shown
by a comparison of the LD50 of histamine diphosphate in sensitized mice
with and without Thephorin. By using the cumulative method of Reed and
Muench11 for the calculation of the LD50 the following values were obtained:
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LD50 of histamine diphosphate injected intra-abdominally in sensitized
mice:
Without pre-treatment : <25.0 mg.
4½2 hours after 2 x 100 mg. Thephorin : 155.7 mg.
4½2 hours after 2 x 50 mg. Thephorin : 89.1 mg.
4½2 hours after 2 x 25 mg. Thephorin : <50.0 mg.
These figures indicate that Thephorin, given per os in doses of 2 x 50
mg./kg. and 2 x 100 mg./kg. protected for a period of more than 4 hours
against doses of histamine at least 3.5 and 6.2 times greater than the 50%
lethal dose.
The higher dose of Thephorin (2 x 100 mg./kg.) also exerted a marked
influence on the anaphylactic shock produced by intravenous injection of
the antigen into the sensitized mice. The results of this experiment can only
TABLE 2
PROTECTION OF SENSITIZED (H. PERTUSSIS VACCINE) MICE TOWARD HISTAMINE
SHOCK AND ANAPHYLACTIC SHOCK (H. PERTUSSIS ANTIGEN) BY ORAL
ADMINISTRATION OF THEPHORIN
No. surviving mice/No. injected mice
Challenging Dose Untreated Thephorin
agent mg./kg. controls 2 x 100mg./kg. 2 x 50mg./kg. 2 x 25mg./kg.
Histamine
diphosphatea 25 7/29 2/2
50 1/12 8/11 6/8 1/4
125 .... 9/14 5/15 1/4
300 .... 3/8
H. pertussis
antigenb 0.5 ml.c 1/11 7/13
a Injected intra-abdominally.
b Injected intravenously.
c 0.5 ml. per mouse.
be considered as of borderline significance, while the corresponding observa-
tions with histamine were found to be not due to chance (p = 0.01 or less).
Discussion
The experiments described above bring forth evidence that the anti-
histaminic drug Thephorin is effective in protecting sensitized mice against
histamine shock produced by 6-12 multiples of the minimal lethal dose of
histamine. Since similar effects were previously described for Bromothen,
it seems likely that other antihistaminic agents will also be effective under
these experimental conditions. The sensitization of the mice by the pre-
treatment with H. pertussis vaccine seems essential, since according to
Mayer and Brousseau6 there was no protective effect of Pyribenzamine and
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Benadryl against the high doses of histamine required to produce toxic
effects in normal mice. In the sensitized mice, on the other hand, consider-
ably lower doses of histamine exerted a toxic effect and could be counter-
acted by the antihistaminic drug. The histamine doses required by the
sensitized animals were, however, still considerably higher than those in
guinea pigs (the minimal lethal dose of histamine diphosphate of 25 mg./kg.
sensitized mouse represents about 30 times the LD50 for guinea pigs) and
correspondingly higher doses of Thephorin had to be given in mice.
Despite certain quantitative differences of drug dosage, the protective
effect of Thephorin in sensitized mice appeared similar to that observed in
guinea pigs. Moreover, mice sensitized by vaccine seem to be particularly
suitable for studies of bacterial allergy since they can be tested for histamine
shock and anaphylaxis.
Concluding this discussion we wish to mention recently published
observations of Globus and Kohn2 and Byers and Moll' on the reaction in
children during immunization against whooping cough. In experiments
with the immunization of rabbits with egg albumen Meier and Buchner7
made very interesting observations on the application of an antihistaminic
drug. The authors protected sensitized rabbits with an antihistaminic drug
-Antistin-and so were able to reinject such animals with larger booster
doses of antigen-egg albumen-to obtain serum with a higher antibody
titer.
Summary
In experiments with Thephorin it was possible to demonstrate the
inhibiting effect of this drug on both histamine shock and anaphylaxis in
mice hypersensitive to H. pertussis vaccine.
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